课题基金 / 基金详情

POLYCYCLIC HYDROCARBON METABOLISM AND CARCINOGENESIS

POLYCYCLIC HYDROCARBON METABOLISM AND CARCINOGENESIS
多环烃代谢与致癌作用
批准号:
3173602
负责人:
EDWARD BRESNICK
金额:
$12.38万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-05-01 至 1991-07-31

项目摘要

项目成果

EDWARD BRESNICK的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Our long-term objective is to understand the molecular basis for resistance and susceptibility to polycyclic hydrocarbon-induced carcinogenesis. We have previously postulated that benzo(a)pyrene (BaP) and 3-methylcholanthrene (3MC) induce cytochrome P450c in the rat after complexing with high affinity and in saturable manner to a 4S cytosolic protein. The latter would translocate into the nucleus, interact with a specific region of the cytochrome P450c gene, and increase transcription of this gene. We have now purified the 4S binding protein and have formulated the following specific aims for our investigations. We will a) produce monoclonal antibody to this purified protein, will characterize the "receptor", localize this binding protein intracellularly, b) isolate the gene for this 4S binding protein by screening a lambda gtll expression library with either the antibody to this protein or with an oligonucleotide probe, c) characterize the gene as to DNA sequence and cis-regulatory elements, d) demonstrate that the 4S binding protein acts as a transcriptional factor through the use of truncated cytochrome P450c gene and in vitro transcriptional assay systems, e) isolate the 9S TCDD-binding protein, prepare monoclonal antibody to it and differentiate this binding protein from the 4S component, f) define the specific regions of interaction of both the 4S and 9S binding proteins with the cytochrome P450c gene, and g) convert a "receptor-negative" cell, such as early passage RL-PR-C rat hepatocytes, to a "receptor-positive" one by transfection and demonstrate the subsequent effects of this transfection on the induction of cytochrome P450c. We hope that through these specific aims we will have a better understanding of the role of the binding proteins in the induction of cytochrome P450c.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MAJOR PROGRAMS FOR CANCER CENTER SUPPORT
  • 批准号:
    6447946
  • 项目类别:
  • 资助金额:
    $24.84万
  • 财政年份:
    2001
  • 负责人:
    EDWARD BRESNICK
  • 依托单位:
MAJOR PROGRAMS FOR CANCER CENTER SUPPORT
  • 批准号:
    6573837
  • 项目类别:
  • 资助金额:
    $24.84万
  • 财政年份:
    2001
  • 负责人:
    EDWARD BRESNICK
  • 依托单位:
MAJOR PROGRAMS FOR CANCER CENTER SUPPORT
  • 批准号:
    6357009
  • 项目类别:
  • 资助金额:
    $24.84万
  • 财政年份:
    2000
  • 负责人:
    EDWARD BRESNICK
  • 依托单位:
MAJOR PROGRAMS FOR CANCER CENTER SUPPORT
  • 批准号:
    6217338
  • 项目类别:
  • 资助金额:
    $13.79万
  • 财政年份:
    1999
  • 负责人:
    EDWARD BRESNICK
  • 依托单位:
国内基金
海外基金
基于合成生物标志物的超多重RNA数字化检测平台用于肿瘤精准诊断和分期评估
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    程子译
  • 依托单位:
RNA m6A修饰通过调控FDX1介导的铜死亡参与补阳还五汤抗脑缺血再灌注损伤作用机制的研究
  • 批准号:
    2026JJ81091
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    刘亮
  • 依托单位:
免标记CRISPR-RNA适配体与门逻辑分子诊断新方法研究
  • 批准号:
    2026JJ50010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    应站明
  • 依托单位:
RNA 结合蛋白HuR与VEGF-D联合调控舌鳞癌侵袭及转移机制的研究
  • 批准号:
    2026JJ80684
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    龚攀
  • 依托单位: